Evidence map›Paper›PMID 27917915›Full record

Trial reportScientific reports2016

Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns Study.

Emma Raitoharju, Ilkka Seppälä, Leo-Pekka Lyytikäinen, Jorma Viikari, Mika Ala-Korpela, Pasi Soininen, Antti J Kangas, Melanie Waldenberger, Norman Klopp, Thomas Illig and 8 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 3 countries.

Emma RaitoharjuDepartment of Clinical Chemistry, Pirkanmaa Hospital District, Fimlab Laboratories, and University of Tampere, School of Medicine, Tampere, Finland.
Ilkka SeppäläDepartment of Clinical Chemistry, Pirkanmaa Hospital District, Fimlab Laboratories, and University of Tampere, School of Medicine, Tampere, Finland.
Leo-Pekka LyytikäinenDepartment of Clinical Chemistry, Pirkanmaa Hospital District, Fimlab Laboratories, and University of Tampere, School of Medicine, Tampere, Finland.
Jorma ViikariDivision of Medicine Turku University Hospital and Department of Medicine, University of Turku, Turku, Finland.
Mika Ala-KorpelaComputational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
Pasi SoininenComputational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
Antti J KangasComputational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
Melanie WaldenbergerResearch Unit of Molecular Epidemiology, Helmholtz Zentrum, German Research Center for Environmental Health, Munich, Germany.
Norman KloppHannover Unified Biobank, Hannover Medical School, Hannover, Germany.
Thomas IlligResearch Unit of Molecular Epidemiology, Helmholtz Zentrum, German Research Center for Environmental Health, Munich, Germany.
Jaana LeiviskäDepartment of Health, National Institute for Health and Welfare, Helsinki and Turku, Finland.
Britt-Marie LooDepartment of Health, National Institute for Health and Welfare, Helsinki and Turku, Finland.
Niku OksalaDepartment of Clinical Chemistry, Pirkanmaa Hospital District, Fimlab Laboratories, and University of Tampere, School of Medicine, Tampere, Finland.
Mika KähönenDepartment of Clinical Physiology, Tampere University Hospital, and School of Medicine, University of Tampere, Tampere, Finland.
Nina Hutri-KähönenDepartment of Pediatrics, University of Tampere and Tampere University Hospital, Tampere, Finland.
Reijo LaaksonenDepartment of Clinical Chemistry, Pirkanmaa Hospital District, Fimlab Laboratories, and University of Tampere, School of Medicine, Tampere, Finland.
Olli RaitakariResearch Centre for Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
Terho LehtimäkiDepartment of Clinical Chemistry, Pirkanmaa Hospital District, Fimlab Laboratories, and University of Tampere, School of Medicine, Tampere, Finland.
Fimlab (Finland) · FITampere University · FIFinnish Institute for Health and Welfare · FIMedizinische Hochschule Hannover · DEHelmholtz Zentrum München · DEMedical Research Council · GBPirkanmaa Hospital District · FITampere University Hospital · FITurku University Hospital · FIUniversity of Eastern Finland · FIUniversity of Oulu · FIUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs are involved in disease development and may be utilized as biomarkers. We investigated the association of blood miRNA levels and a) fatty liver (FL), b) lipoprotein and lipid pathways involved in liver lipid accumulation and c) levels of predicted mRNA targets in general population based cohort. Blood microRNA profiling (TaqMan OpenArray), genome-wide gene expression arrays and nuclear magnetic resonance metabolomics were performed for Young Finns Study participants aged 34-49 years (n = 871). Liver fat status was assessed ultrasonographically. Levels of hsa-miR-122-5p and -885-5p were up-regulated in individuals with FL (fold change (FC) = 1.55, p = 1.36 * 10

Indexed as

AdolescentAdultChildChild, PreschoolFatty LiverFemaleFinlandFollow-Up StudiesGenome-Wide Association StudyHumansLipoproteinsMaleMicroRNAsMiddle AgedUltrasonographyLipoproteinsMicroRNAsMIRN122 microRNA, humanMIRN885 microRNA, human

Identifiers

PMID27917915
PMCPMC5137183
OpenAlexW2559819932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.